Pliant Therapeutics (PLRX) Current Leases (2021 - 2026)
Pliant Therapeutics (PLRX) reported Current Leases of $1.7 million for Q1 2026, up 122.18% year-over-year from $771000.0 in Q1 2025, and up 18.38% quarter-over-quarter from $1.4 million in Q4 2025.
Pliant Therapeutics (PLRX) Current Leases (2021 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has 6 years of Current Leases data on file, last reported at $1.7 million in Q1 2026.
- Current Leases for Q1 2026 came in at $1.7 million, up 122.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (up 122.18% YoY), and the FY2025 annual result was $1.4 million, up 166.97% from the prior year.
- Current Leases climbed to $1.7 million in Q1 2026 per PLRX's latest filing, from $1.4 million in the prior quarter.
- Over five years, Current Leases peaked at $2.6 million in Q3 2022 and troughed at $98000.0 in Q2 2024.
- A 5-year average of $1.5 million and a median of $1.4 million in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2025: Current Leases tumbled 95.61% in 2024, then surged 1150.0% in 2025.
- A 5-year view of Current Leases shows it stood at $2.5 million in 2022, then tumbled by 46.36% to $1.3 million in 2023, then tumbled by 58.88% to $542000.0 in 2024, then jumped by 166.97% to $1.4 million in 2025, then increased by 18.38% to $1.7 million in 2026.
- Business Quant data shows PLRX's Current Leases at $1.7 million in Q1 2026, $1.4 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | 1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 771,000.00 |
| Dec 31, 2024 | 542,000.00 |
| Sep 30, 2024 | 322,000.00 |
| Jun 30, 2024 | 98,000.00 |
| Mar 31, 2024 | 773,000.00 |
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 2.06 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 2.38 Mn |
| Dec 31, 2022 | 2.46 Mn |
| Sep 30, 2022 | 2.65 Mn |
| Jun 30, 2022 | 2.04 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 1.87 Mn |